Skip to main content
Skip to content

NAICS 424210 Quarterly Industry Report

Drugs and Druggists' Sundries Merchant Wholesalers

Comprehensive industry research for valuation professionals, business owners, buyers, and lenders

NAICS Code: 424210Sector: Wholesale Trade (42)Updated: Q1 2026

About This Report

This Fair Market Value industry report for NAICS 424210 synthesizes data from the U.S. Census Bureau[5], Bureau of Labor Statistics[7], and Small Business Administration[6] to profile the pharmaceutical and druggists' sundries wholesale sector. Our research team analyzes drug distribution data and regulatory compliance patterns to provide accurate market intelligence for business valuation. The report covers SBA size standards, related NAICS classifications, and the regulatory framework governing pharmaceutical distribution. Fair Market Value updates this NAICS 424210 profile quarterly to reflect new Census releases and pharmaceutical industry developments.

Industry Snapshot

Key metrics for the drugs and druggists' sundries merchant wholesalers industry.

Establishments
22,978
2024 annual average[1]
5-Year Growth
-13.9%
Establishment count, 2017–2022[2]
Avg. SBA Loan
$675K
7(a) program, FY 2025[4]
Industry Revenue
$1.3B
2022 Economic Census[2]
Share of Wholesale Trade
2.3%
By establishment count, 2022 Census[2]
NAICS Sector
42
Wholesale Trade

Industry Definition & Overview

Drugs and Druggists' Sundries Merchant Wholesalers (NAICS 424210) encompasses establishments primarily engaged in the merchant wholesale distribution of biological and medical products, botanical drugs and herbs, and pharmaceutical products intended for internal or external consumption. Product forms include tablets, capsules, vials, ampoules, ointments, powders, solutions, and suspensions. This classification also covers wholesale distribution of in-vitro and in-vivo diagnostics, vitamins, over-the-counter medications, and health and beauty products sold through pharmacy channels. Pharmaceutical wholesale distribution operates through a highly concentrated industry structure dominated by a small number of national distributors that handle the majority of prescription drug volume. These large distributors operate sophisticated automated distribution centers with temperature-controlled storage, lot tracking, and serialization capabilities mandated by the Drug Supply Chain Security Act (DSCSA). Smaller regional and specialty distributors serve niche markets including independent pharmacies, long-term care facilities, veterinary clinics, and specialty pharmacy channels. According to the U.S. Census Bureau[5], merchant wholesalers take title to pharmaceutical products before distributing them to pharmacies, hospitals, and other dispensing locations. The SBA[6] sets the size standard at 250 employees for this industry. Roughly 7,177 establishments operate nationwide, employing about 306,601 workers. Drug wholesale distribution requires DEA registration for controlled substances handling, state pharmacy board licensing, and FDA compliance for drug storage and transportation. Specialty pharmaceuticals, including biologics and high-cost therapies, have shifted distribution economics by concentrating enormous dollar volumes in limited-distribution networks. Generic drug distribution operates on thin margins with high volumes, while brand-name drugs generate revenue through manufacturer fee-for-service distribution agreements.

What's Included in This Industry

  • Wholesale distribution of prescription pharmaceutical drugs
  • Distribution of over-the-counter medications and remedies
  • Wholesale of biological products and vaccines
  • Distribution of in-vitro and in-vivo diagnostic products
  • Wholesale of vitamins, supplements, and nutraceuticals
  • Distribution of botanical drugs and herbal products
  • Wholesale of health and beauty products for pharmacy channels
  • Distribution of veterinary pharmaceuticals and biologicals
  • Wholesale of medical devices distributed through drug channels
  • Distribution of controlled substances under DEA authorization

NAICS Classification Hierarchy

NAICS classification hierarchy for 424210
LevelDescriptionCode
SectorWholesale Trade42
SubsectorMerchant Wholesalers, Nondurable Goods424
Industry GroupDrugs and Druggists' Sundries Merchant Wholesalers4242
NAICS IndustryDrugs and Druggists' Sundries Merchant Wholesalers42421
National IndustryDrugs and Druggists' Sundries Merchant Wholesalers424210

Related NAICS Codes

Related NAICS codes and their relationships
CodeDescriptionRelationship
424120Stationery and Office Supplies Merchant WholesalersDistributes stationery and office supplies through wholesale channels, sharing some retail pharmacy customer overlap for front-end store merchandise categories
424990Other Miscellaneous Nondurable Goods Merchant WholesalersHandles other miscellaneous nondurable goods wholesale distribution, with some overlap in health and beauty products sold outside traditional pharmacy channels
424910Farm Supplies Merchant WholesalersDistributes farm supplies and agricultural chemicals, sharing some veterinary pharmaceutical distribution overlap with druggists' sundries wholesalers
325411Medicinal and Botanical ManufacturingManufactures medicinal and botanical products that represent a core upstream supply category for pharmaceutical wholesale distribution networks
325412Pharmaceutical Preparation ManufacturingProduces pharmaceutical preparations including tablets, capsules, and other dosage forms that flow through wholesale distribution to pharmacies and hospitals
325413In-Vitro Diagnostic Substance ManufacturingManufactures in-vitro diagnostic substances distributed through pharmaceutical wholesale channels to laboratories, clinics, and hospital testing facilities

Geographic Concentration

Top states by share of national establishments.

Top 10 states by establishment share for Drugs and Druggists' Sundries Merchant Wholesalers
#State% Est.Total Est.
1California
19.3%
1,926
2New York
9.4%
932
3Florida
9.2%
919
4Texas
6.2%
619
5New Jersey
6.2%
614
6Pennsylvania
3.1%
310
7Illinois
3.0%
294
8Ohio
2.5%
253
9Georgia
2.5%
249
10North Carolina
2.5%
248
Source: County Business Patterns, U.S. Census Bureau[3]

SBA Lending Summary

344
Total SBA Loans
$232.2M
Total Loan Volume
$675K
Average Loan Size
11 yrs
Average Loan Term
10.39%
Average Interest Rate
2,288
Jobs Supported
Source: SBA 7(a) Program Data, U.S. Small Business Administration — FY 2025[4]
Key Insight: The SBA[6] classifies NAICS 424210 under merchant wholesale trade with a size standard of 250 employees. Businesses at or below this threshold qualify as small for federal contracting preferences and SBA loan programs. Pharmaceutical wholesalers can access SBA 7(a) loans[8] for inventory acquisition and compliance infrastructure investment. Firms expanding cold chain storage or automated distribution facilities may qualify for 504 loans[9]. Regulatory compliance costs for DEA registration, DSCSA serialization, and state licensing create substantial capital requirements that SBA-backed financing helps address.

Top SBA Lenders

Top SBA lenders by volume for this industry
#LenderLoansVolumeAvg Loan
1Live Oak Banking Company16$37.6M$2.4M
2Port 51 Lending LLC8$32.9M$4.1M
3City National Bank of Florida8$28.0M$3.5M
4Paradise Bank8$22.5M$2.8M
5Zions Bank, A Division of8$15.4M$1.9M
View Full SBA Lending Details for NAICS 424210Includes top lenders, geographic distribution, annual trends, and loan-level analysis

Frequently Asked Questions

Common questions about this industry.

What types of businesses fall under NAICS 424210?
NAICS 424210 includes merchant wholesalers distributing prescription drugs, over-the-counter medications, biologicals, vaccines, vitamins, diagnostics, and health products. These firms buy from pharmaceutical manufacturers and distribute to pharmacies, hospitals, clinics, and other healthcare providers. Source: U.S. Census Bureau[5]
How is the pharmaceutical wholesale industry structured?
Three major national distributors handle the bulk of prescription drug volume in the United States. Smaller regional wholesalers serve independent pharmacies and local markets. Specialty distributors handle limited-distribution drugs and biologics. All distributors must comply with DSCSA serialization requirements and maintain proper licensing.
What is the SBA size standard for NAICS 424210?
The SBA sets the size standard at 250 employees for drugs and druggists' sundries merchant wholesalers. Businesses at or below this level qualify as small for federal contracting preferences and SBA financing programs. Source: SBA Size Standards[6]
What NAICS codes are related to pharmaceutical wholesaling?
Key related codes include 325411 (medicinal manufacturing), 325412 (pharmaceutical preparation manufacturing), 325413 (diagnostic substance manufacturing), and 325414 (biological product manufacturing). These represent the upstream manufacturing supply chain. Source: Census NAICS[5]
What industries work closely with pharmaceutical wholesalers?
Primary customers include retail pharmacy chains, independent pharmacies, hospital pharmacy departments, long-term care facilities, and specialty pharmacies. Upstream partners include brand-name and generic drug manufacturers. Third-party logistics providers handle some distribution functions under pharma compliance requirements.
What products are included in NAICS 424210?
Products include prescription drugs (brand and generic), over-the-counter medications, vaccines, biologics, diagnostic products, vitamins, botanical products, veterinary drugs, and health and beauty items for pharmacy distribution. Controlled substances require DEA registration. Source: Census Bureau[5]
Can pharmaceutical wholesalers get SBA loans?
Yes, small businesses under NAICS 424210 can access SBA 7(a) loans for inventory and working capital, 504 loans for distribution center facilities, and Express loans for faster processing. Regulatory compliance infrastructure including cold chain storage creates additional capital investment needs. Source: SBA Loan Programs[10]
Where are pharmaceutical wholesalers concentrated?
Major pharmaceutical distribution centers locate near population centers and healthcare market concentrations. Key hubs include the Northeast corridor, California, Texas, Ohio, and Illinois. Specialty drug distributors often concentrate near major medical centers and research hospitals. Source: BLS QCEW[11]

Sources & References

Government datasets and editorial sources used in this report.

  1. [1]U.S. Bureau of Labor Statistics, Quarterly Census of Employment and Wages bls.gov
  2. [2]U.S. Census Bureau, Economic Census census.gov
  3. [3]U.S. Census Bureau, County Business Patterns census.gov
  4. [4]U.S. Small Business Administration, SBA 7(a) Loan Program Data data.sba.gov
  5. [5]U.S. Census Bureau census.gov
  6. [6]SBA sba.gov
  7. [7]Bureau of Labor Statistics bls.gov
  8. [8]SBA 7(a) loans sba.gov
  9. [9]504 loans sba.gov
  10. [10]SBA Loan Programs sba.gov
  11. [11]BLS QCEW bls.gov

Disclaimer

This publication has been prepared by Fair Market Value (“Fair Market Value”) for informational purposes only. It is provided on an “as-is” and “as available” basis. Fair Market Value makes no representations or warranties, express or implied, regarding the merchantability, fitness for a particular purpose, completeness, or accuracy of the data or information contained herein. This publication is not intended to be, and should not be construed as, professional financial, legal, tax, or investment advice. Users should consult with qualified professionals before making any financial or business decisions based on the information presented.

To the extent permitted by law, Fair Market Value disclaims all liability for loss or damage, direct and indirect, suffered or incurred by any person resulting from the use of, or reliance upon, the data in this publication.

Copyright © 2026 Fair Market Value. All rights reserved. All data, information, articles, graphs, and content contained in this publication are copyrighted works and Fair Market Value hereby reserves all rights. No part of this publication may be copied, reproduced, republished, uploaded to a third party, or distributed without the prior written permission of Fair Market Value.